| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2377506
Max Phase: Preclinical
Molecular Formula: C14H9Br2NO2
Molecular Weight: 383.04
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cn1c(-c2cc(=O)c3ccccc3o2)cc(Br)c1Br
Standard InChI: InChI=1S/C14H9Br2NO2/c1-17-10(6-9(15)14(17)16)13-7-11(18)8-4-2-3-5-12(8)19-13/h2-7H,1H3
Standard InChI Key: MAHTUIAPTCLIIS-UHFFFAOYSA-N
Associated Targets(Human)
Caco-2 12174 Activities
WRL68 207 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PA-1 704 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MCF7 126967 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 383.04 | Molecular Weight (Monoisotopic): 380.9000 | AlogP: 4.32 | #Rotatable Bonds: 1 |
| Polar Surface Area: 35.14 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.43 | CX LogD: 3.43 |
| Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.63 | Np Likeness Score: 0.41 |
References
| 1. Rane RA, Sahu NU, Gutte SD, Mahajan AA, Shah CP, Bangalore P.. (2013) Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents., 63 [PMID:23584542] [10.1016/j.ejmech.2013.03.029] |
Source
Source(1):